Value of total cholesterol readings earlier versus later in life to predict cardiovascular risk
Andreas Leiherer,
Hanno Ulmer,
Axel Muendlein,
Christoph H. Saely,
Alexander Vonbank,
Peter Fraunberger,
Bernhard Foeger,
Eva Maria Brandtner,
Wolfgang Brozek,
Gabriele Nagel,
Emanuel Zitt,
Heinz Drexel,
Hans Concin
Affiliations
Andreas Leiherer
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch A-6800, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein; Medical Central Laboratories, Feldkirch, Austria; Corresponding author.
Hanno Ulmer
Agency for Preventive and Social Medicine, Bregenz, Austria; Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria
Axel Muendlein
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch A-6800, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
Christoph H. Saely
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch A-6800, Austria; Department of Internal Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
Alexander Vonbank
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch A-6800, Austria; Department of Internal Medicine I, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
Peter Fraunberger
Private University of the Principality of Liechtenstein, Triesen, Liechtenstein; Medical Central Laboratories, Feldkirch, Austria
Bernhard Foeger
Agency for Preventive and Social Medicine, Bregenz, Austria
Eva Maria Brandtner
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch A-6800, Austria
Wolfgang Brozek
Agency for Preventive and Social Medicine, Bregenz, Austria
Gabriele Nagel
Agency for Preventive and Social Medicine, Bregenz, Austria; Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany
Emanuel Zitt
Agency for Preventive and Social Medicine, Bregenz, Austria; Department of Internal Medicine III, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
Heinz Drexel
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch A-6800, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein; Drexel University College of Medicine, Philadelphia, PA, United States; Department of Internal Medicine, Academic Teaching Hospital Bregenz, Bregenz, Austria
Hans Concin
Agency for Preventive and Social Medicine, Bregenz, Austria
Background: Prognostic implications of blood cholesterol may differ at different stages of life. This cohort study compares the value of total cholesterol (TC) readings earlier versus later in life for the prediction of coronary atherosclerosis, cardiovascular events, and cardiovascular death. Methods: In a cardiovascular observation study (CVOS) we performed coronary angiography and prospectively recorded cardiovascular events in 1090 patients over up to 19 years. These patients had participated in a health survey (HS) 15 years prior to the CVOS baseline. TC was measured twice, first at the earlier HS and then later at CVOS recruiting. Findings: Patients in the highest versus the lowest TC-category of the HS had an OR of 4.30 [2.41–7.65] for significant CAD at angiography, a HR of 1.74 [1.10–2.76] for cardiovascular events, and a HR of 7.55 [1.05–54.49] for cardiovascular death after multivariate adjustment. In contrast, TC as measured at the baseline of the CVOS was neither significantly associated with significant CAD (OR= 0.75 [0.49–1.13]) nor with cardiovascular events or death during follow-up (HR= 0.86 [0.62–1.18] and 0.79 [0.41–1.53], respectively). Moreover, the ESC/EAS-SCORE was found to be more powerful in predicting cardiovascular mortality when using earlier instead of later TC, with a continuous net reclassification improvement of 0.301 (p<0.001). Interpretation: Early measurement not only enables early intervention in keeping with the concept of lifelong exposure to atherogenic lipoproteins. These data also suggest that cardiovascular risk prediction is more accurate if using earlier in life TC readings. Funding: The present study did not receive any particular funding